Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

AMNEAL PHARMACEUTICALS, INC Total Assets 2010-2023 | AMRX

AMNEAL PHARMACEUTICALS, INC total assets from 2010 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
AMNEAL PHARMACEUTICALS, INC Annual Total Assets
(Millions of US $)
2023 $3,473
2022 $3,799
2021 $3,940
2020 $4,006
2019 $3,666
2018 $4,353
2017 $1,342
2016 $1,823
2015 $1,922
2014 $1,079
2013 $997
2012 $864
2011 $794
2010 $693
2009 $661
AMNEAL PHARMACEUTICALS, INC Quarterly Total Assets
(Millions of US $)
2023-12-31 $3,473
2023-09-30 $3,687
2023-06-30 $3,701
2023-03-31 $3,627
2022-12-31 $3,799
2022-09-30 $3,874
2022-06-30 $4,041
2022-03-31 $3,889
2021-12-31 $3,940
2021-09-30 $3,974
2021-06-30 $4,023
2021-03-31 $3,960
2020-12-31 $4,006
2020-09-30 $4,038
2020-06-30 $4,057
2020-03-31 $4,391
2019-12-31 $3,666
2019-09-30 $3,704
2019-06-30 $4,262
2019-03-31 $4,385
2018-12-31 $4,353
2018-09-30 $4,582
2018-06-30 $4,545
2018-03-31 $1,221
2017-12-31 $1,342
2017-09-30 $1,649
2017-06-30 $1,701
2017-03-31 $1,696
2016-12-31 $1,823
2016-09-30 $2,120
2016-06-30 $1,850
2016-03-31 $1,886
2015-12-31 $1,922
2015-09-30 $1,996
2015-06-30 $2,032
2015-03-31 $1,782
2014-12-31 $1,079
2014-09-30 $1,092
2014-06-30 $1,059
2014-03-31 $982
2013-12-31 $997
2013-09-30 $1,015
2013-06-30 $1,010
2013-03-31 $1,009
2012-12-31 $864
2012-09-30 $901
2012-06-30 $958
2012-03-31 $903
2011-12-31 $794
2011-09-30 $752
2011-06-30 $744
2011-03-31 $718
2010-12-31 $693
2010-09-30 $705
2010-06-30 $848
2010-03-31 $845
2009-12-31 $661
2009-09-30 $530
2009-06-30 $516
2009-03-31 $512
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.664B $2.394B
Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $67.003B 27.54
Chugai Pharmaceutical (CHGCY) Japan $52.278B 22.70
Takeda Pharmaceutical (TAK) Japan $41.902B 6.79
Merck (MKGAF) Germany $20.162B 19.02
Astellas Pharma (ALPMY) Japan $17.192B 24.36
Shionogi (SGIOY) Japan $14.152B 12.24
Sandoz Group AG (SDZNY) Switzerland $13.930B 0.00
Neurocrine Biosciences (NBIX) United States $13.135B 54.54
United Therapeutics (UTHR) United States $11.197B 11.99
Catalent (CTLT) United States $10.040B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.926B 7.02
Ionis Pharmaceuticals (IONS) United States $5.929B 0.00
Revolution Medicines (RVMD) United States $5.751B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Alpine Immune Sciences (ALPN) United States $4.231B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.219B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.991B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.767B 0.00
Indivior (INDV) United States $2.554B 11.87
Evotec AG (EVO) Germany $2.505B 0.00
Summit Therapeutics (SMMT) United States $2.456B 0.00
Corcept Therapeutics (CORT) United States $2.389B 24.16
Dyne Therapeutics (DYN) United States $2.056B 0.00
PTC Therapeutics (PTCT) United States $1.940B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.804B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.786B 18.45
NewAmsterdam Pharma (NAMS) Netherlands $1.779B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.725B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.588B 27.80
Avadel Pharmaceuticals (AVDL) Ireland $1.570B 0.00
Ardelyx (ARDX) United States $1.508B 0.00
4D Molecular Therapeutics (FDMT) United States $1.292B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.240B 11.65
Pacira BioSciences (PCRX) United States $1.221B 12.15
Soleno Therapeutics (SLNO) United States $1.217B 0.00
Collegium Pharmaceutical (COLL) United States $1.139B 7.01
Xencor (XNCR) United States $1.123B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.060B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.913B 0.00
Cronos Group (CRON) Canada $0.905B 0.00
Cassava Sciences (SAVA) United States $0.849B 0.00
USANA Health Sciences (USNA) United States $0.849B 13.37
ARS Pharmaceuticals (SPRY) United States $0.817B 0.00
Enliven Therapeutics (ELVN) United States $0.809B 0.00
Sage Therapeutics (SAGE) United States $0.801B 0.00
Relay Therapeutics (RLAY) United States $0.782B 0.00
Ocular Therapeutix (OCUL) United States $0.776B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.722B 0.00
Silence Therapeutics (SLN) United Kingdom $0.678B 0.00
Savara (SVRA) United States $0.664B 0.00
Siga Technologies (SIGA) United States $0.593B 8.78
Lyell Immunopharma (LYEL) United States $0.567B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.557B 0.00
Verve Therapeutics (VERV) United States $0.555B 0.00
OmniAb (OABI) United States $0.547B 0.00
Korro Bio (KRRO) United States $0.535B 0.00
Exscientia (EXAI) United Kingdom $0.513B 0.00
Altimmune (ALT) United States $0.490B 0.00
KalVista Pharmaceuticals (KALV) United States $0.488B 0.00
ProKidney (PROK) United States $0.468B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.454B 0.00
Larimar Therapeutics (LRMR) United States $0.417B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.412B 0.00
Lexeo Therapeutics (LXEO) United States $0.397B 0.00
Heron Therapeutics (HRTX) United States $0.397B 0.00
Tourmaline Bio (TRML) United States $0.396B 0.00
Organogenesis (ORGO) United States $0.383B 72.50
Harrow (HROW) United States $0.370B 0.00
Esperion Therapeutics (ESPR) United States $0.369B 0.00
Nature's Sunshine Products (NATR) United States $0.363B 20.31
Bioventus (BVS) United States $0.355B 0.00
Fractyl Health (GUTS) United States $0.314B 0.00
Lyra Therapeutics (LYRA) United States $0.310B 0.00
Aquestive Therapeutics (AQST) United States $0.301B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.296B 0.00
Akebia Therapeutics (AKBA) United States $0.285B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.282B 0.00
ESSA Pharma (EPIX) Canada $0.280B 0.00
Black Diamond Therapeutics (BDTX) United States $0.272B 0.00
Metagenomi (MGX) United States $0.258B 0.00
Nanobiotix S.A (NBTX) France $0.255B 0.00
Adherex Technologies (FENC) United States $0.253B 0.00
Xeris Biopharma Holdings (XERS) United States $0.244B 0.00
Pyxis Oncology (PYXS) United States $0.242B 0.00
Telomir Pharmaceuticals (TELO) United States $0.236B 0.00
Nektar Therapeutics (NKTR) United States $0.228B 0.00
Aldeyra Therapeutics (ALDX) United States $0.227B 0.00
Conduit Pharmaceuticals (CDT) United States $0.227B 0.00
Foghorn Therapeutics (FHTX) United States $0.226B 0.00
Avita Medical (RCEL) United States $0.222B 0.00
Acrivon Therapeutics (ACRV) United States $0.213B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Prelude Therapeutics (PRLD) United States $0.204B 0.00
Century Therapeutics (IPSC) United States $0.200B 0.00
Zevra Therapeutics (ZVRA) United States $0.196B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.189B 0.00
Profound Medical (PROF) Canada $0.189B 0.00
Achieve Life Sciences (ACHV) Canada $0.154B 0.00
CytoDyn (CYDY) United States $0.154B 0.00
Incannex Healthcare (IXHL) Australia $0.151B 0.00
MediWound (MDWD) Israel $0.150B 0.00
Regulus Therapeutics (RGLS) United States $0.139B 0.00
Elite Pharmaceuticals (ELTP) United States $0.139B 13.00
Karyopharm Therapeutics (KPTI) United States $0.135B 0.00
VAXART, INC (VXRT) United States $0.134B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.127B 2.67
GlycoMimetics (GLYC) United States $0.124B 0.00
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Relmada Therapeutics (RLMD) United States $0.121B 0.00
Citius Pharmaceuticals (CTXR) United States $0.120B 0.00
FibroGen (FGEN) United States $0.114B 0.00
Inotiv (NOTV) United States $0.111B 0.00
Eliem Therapeutics (ELYM) United States $0.107B 0.00
OptiNose (OPTN) United States $0.101B 0.00
ProPhase Labs (PRPH) United States $0.095B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
Aclaris Therapeutics (ACRS) United States $0.088B 0.00
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.076B 0.00
Assertio Holdings (ASRT) United States $0.073B 5.95
Journey Medical (DERM) United States $0.069B 0.00
Tempest Therapeutics (TPST) United States $0.069B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Mural Oncology (MURA) $0.060B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
SCYNEXIS (SCYX) United States $0.054B 0.81
BioLineRx (BLRX) Israel $0.052B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Jaguar Animal Health (JAGX) United States $0.043B 0.00
Rafael Holdings (RFL) United States $0.043B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
Unicycive Therapeutics (UNCY) United States $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
JanOne (JAN) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.034B 0.00
VYNE Therapeutics (VYNE) United States $0.032B 0.00
Nutriband (NTRB) United States $0.031B 0.00
Protara Therapeutics (TARA) United States $0.030B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Surrozen (SRZN) United States $0.030B 0.00
NRx Pharmaceuticals (NRXP) United States $0.030B 0.00
Lipocine (LPCN) United States $0.028B 0.00
DURECT (DRRX) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.67
CERo Therapeutics Holdings (CERO) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.022B 1.09
TherapeuticsMD (TXMD) United States $0.021B 0.00
Addex Therapeutics (ADXN) Switzerland $0.021B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Aptorum Group (APM) United Kingdom $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Alaunos Therapeutics (TCRT) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Inhibikase Therapeutics (IKT) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.008B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.21
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.11